{
    "organizations": [],
    "uuid": "b87d97b069c424ab52da266bc56dc76c139cabc7",
    "author": "",
    "url": "https://www.reuters.com/article/brief-mimedx-enrolls-first-patient-in-it/brief-mimedx-enrolls-first-patient-in-its-phase-2b-clinical-trial-of-amniofix-injectable-for-treatment-of-osteoarthritis-of-the-knee-idUSASC09TYM",
    "ord_in_thread": 0,
    "title": "BRIEF-MiMedx Enrolls First Patient In Its Phase 2B Clinical Trial Of Amniofix® Injectable For Treatment Of Osteoarthritis Of The Knee",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Market News March 28, 2018 / 12:25 PM / Updated 8 minutes ago BRIEF-MiMedx Enrolls First Patient In Its Phase 2B Clinical Trial Of Amniofix® Injectable For Treatment Of Osteoarthritis Of The Knee Reuters Staff 1 Min Read \nMarch 28 (Reuters) - MiMedx Group Inc: \n* MIMEDX ENROLLS FIRST PATIENT IN ITS PHASE 2B CLINICAL TRIAL OF RMAT DESIGNATED AMNIOFIX® INJECTABLE FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE Source text for Eikon: Further company coverage:",
    "published": "2018-03-28T15:24:00.000+03:00",
    "crawled": "2018-03-28T15:34:40.042+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "market",
        "news",
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "enrolls",
        "first",
        "patient",
        "phase",
        "2b",
        "clinical",
        "trial",
        "injectable",
        "treatment",
        "osteoarthritis",
        "knee",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "mimedx",
        "group",
        "inc",
        "mimedx",
        "enrolls",
        "first",
        "patient",
        "phase",
        "2b",
        "clinical",
        "trial",
        "rmat",
        "designated",
        "injectable",
        "treatment",
        "osteoarthritis",
        "knee",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}